Scleredema accompanied by IgG‐λ monoclonal gammopathy

Scleredema accompanied by IgG‐λ monoclonal gammopathy

Bibliographic Details
Main Authors:	Haruka Goto, Mutsumi Moriki, Yuko Sano, Hiroaki Yagi, Yoshiki Tokura
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-08-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12073

Similar Items

Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series
by: Jing Liu, et al.
Published: (2022-10-01)

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
by: David F. Moreno, et al.
Published: (2021-04-01)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
by: J. Bladé
Published: (2023-05-01)

Monoclonal Gammopathy of Thrombotic Significance
by: Vasiliki Gkalea, et al.
Published: (2023-01-01)

Monoclonal gammopathy of “ocular” significance
by: Sezen Karakus, et al.
Published: (2019-09-01)

<i>MYD88</i> Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies
by: Miguel Alcoceba, et al.
Published: (2022-05-01)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
by: Ina Kreyberg, MD, PhD, et al.
Published: (2023-11-01)

The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity
by: Anna Timofeeva, et al.
Published: (2022-02-01)

Acute Kidney Injury in Monoclonal Gammopathies
by: Paolo Menè, et al.
Published: (2021-08-01)

Necrobiotic Xanthogranuloma as Sign of Monoclonal Gammopathy
by: Claudio Conforti, et al.
Published: (2022-10-01)

Oligosecretory monoclonal gammopathy with renal involvement
by: L V Kozlovskaya, et al.
Published: (2016-12-01)

Scleredema diabeticorum – A case report
by: O.I. Ezejiofor, et al.
Published: (2015-07-01)

Scleredema-associated IgA myeloma with myelofibrosis in a young adult: a case report
by: Renu Saxena, et al.
Published: (2008-12-01)

Impact of IgG subclass on monoclonal antibody developability
by: Paul Cain, et al.
Published: (2023-12-01)

A case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy
by: Helana Ghali, BS, et al.
Published: (2024-05-01)

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by: Johannes P. M. van de Mortel, et al.
Published: (2022-10-01)

Prevalence of MGCS Among Patients With Monoclonal Gammopathies
by: Foteini Theodorakakou, et al.
Published: (2023-06-01)

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
by: David F. Moreno, et al.
Published: (2021-10-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Scleredema of Buschke leading to an ulcerated plaque on the neck
by: Thu M. Truong, et al.
Published: (2024-02-01)

Impact of IgG subclass on molecular properties of monoclonal antibodies
by: Yu Tang, et al.
Published: (2021-01-01)

Monoclonal gammopathy with systemic amylodosis: an evaluation of diagnostic elements
by: Chellappah Thambiah, Subashini, et al.
Published: (2011)

Recent advances in C3 glomerulopathy with monoclonal gammopathy
by: Yi-lan Cheng, et al.
Published: (2024-03-01)

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
by: Andrea Visentin, et al.
Published: (2022-03-01)

Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
by: Vanessa Innao, et al.
Published: (2021-05-01)

Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
by: Paolo Menè, et al.
Published: (2020-06-01)

Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal
by: Rafael Ríos-Tamayo, et al.
Published: (2022-10-01)

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
by: Yi Da, et al.
Published: (2022-05-01)

Myeloma‐like Castleman disease with plasmacytosis and monoclonal gammopathy
by: Chieh‐Yu Hsieh, et al.
Published: (2022-10-01)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
by: Aðalbjörg Ýr Sigurbergsdóttir, et al.
Published: (2022-04-01)

<i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges
by: Tina Bagratuni, et al.
Published: (2023-09-01)

IgA lambda oligoclonal gammopathy in multiple myeloma
by: İbrahim Tek, et al.
Published: (2010-06-01)

IgA lambda oligoclonal gammopathy in multiple myeloma
by: İbrahim Tek, et al.
Published: (2010-06-01)

Contributions of the bone microenvironment to monoclonal gammopathy of undetermined significance pathogenesis
by: Gámez, B, et al.
Published: (2018)

Seek and ye shall find: monoclonal gammopathy of undetermined significance
by: Luz Tarín-Arzaga, et al.
Published: (2023-04-01)

New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
by: Karolina Woziwodzka, et al.
Published: (2020-05-01)

Case report: Schnitzler-like syndrome without monoclonal gammopathy
by: Anna Sophie Wesselmann, et al.
Published: (2023-03-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Epidemiology of monoclonal gammopathy in Morocco – A hospital‐based study
by: Zohra Ouzzif, et al.
Published: (2023-05-01)

Optimization of workflow and screening panels for the detection of malignant monoclonal gammopathies
by: Oliveros Conejero Raquel, et al.
Published: (2020-07-01)